跳至主要内容
临床试验/NCT02690870
NCT02690870Unknown4 期

Comparison of Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF: a Prospective Cohort Study

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University0 个研究点目标入组 210 人开始时间: 2017年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
210
主要终点
clinical pregnancy rate

研究概览

简要总结

The purpose of this prospective cohort study is to compare IVF outcome between tamoxifen and clomiphene citrate in mild stimulation.

详细描述

The reported prevalence of poor ovarian responders amongst patients undergoing IVF-ET is 9%-24%, and morbidity must be higher nowadays. For these women, Mild stimulation has been an important ovulation induction protocol. Clomiphene citrate(CC) and tamoxifen(TMX) are commonly used in mild stimulation protocol. It's reported that CC has adverse effect on growth of endrometrium and results in thin endrometrium(≤7mm) which maybe affect pregnancy rate. However, TMX has estrogen-like effect on the endrometrium that may be helpful to increase endormetrial thickness. The reported results about comparing CC with TMX showed that they had similar ovulation rate. Prospective study is necessary to confirm whether TMX is superior to CC on the IVF outcome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
37 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age between 37 and 42;
  • BMI≤23kg/m2;
  • ≤3 oocytes with a conventional stimulation protocol;
  • AFC<5 follicles or AMH<1.1 ng/ml on the day 1 to 5 of the menses;
  • Cause of Infertiity: tubal factor, male factor, diminished ovarian reserve.

排除标准

  • endormetrial polyp, endormetrial cancer,intrauterine adhesions,uterine fibroids that affects uterine cavity
  • Endometriosis, adenomyosis
  • The diameter of Hydrosalpinx >2cm

研究组 & 干预措施

clomiphene

Active Comparator

All patients will have serum hormone examination and be monitored by transvaginal ultrasound for ovaries on the day 3 of the menses(D3).Patients in clomiphene group will take 100 mg of CC oral tablets daily from D3 for 5 days.All patients will have sexual hormone determination and be monitored by transvaginal ultrasound for the mean follicular diameter and endometrial thickness on the day 8 of the cycle.The investigators will add HMG and GnRH-ant according to follicular diameter,E2 and LH. Human chorionic gonadotropin(hCG) (5000-10000 IU IM) will be given when one follicle measured at least 18 mm is found. IVF or ICSI will be performed 34-36 h after hCG injection. All patients will receive luteal phase support with progesterone 60 mg im qd for 2 weeks.

干预措施: Clomiphene (Drug)

tamoxifen

Experimental

All patients will have serum hormone examination and be monitored by transvaginal ultrasound for ovaries on the day 3 of the menses(D3).Patients in the tamoxifen group will take 20 mg of tamoxifen oral tablets daily from D3 for 5 days.All patients will check serum E2 and be monitored by transvaginal ultrasound for the mean follicular diameter and endometrial thickness on the day 8 of the cycle. The investigators will add HMG and GnRH-ant according to follicular diameter,E2 and LH. Human chorionic gonadotropin(hCG) (5000-10000 IU IM) will be given when one follicle measured at least 18 mm is found. IVF or ICSI will be performed 34-36 h after hCG administration. All patients will receive luteal phase support with progesterone 60 mg im qd for 2 weeks.

干预措施: Tamoxifen (Drug)

结局指标

主要结局

clinical pregnancy rate

时间窗: four weeks after embryo transfer

次要结局

  • endrometrial pattern and thickness on the day of HCG administration(on the HCG day)
  • cycle cancellations for thin endrometrial thickness(on the HCG day)
  • the number of follicular diameter≥10mm and sexual hormone test on the HCG day(on the HCG day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haiyan Lin

attending doctor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

相似试验